Glycogen Synthase Kinase 3, antagonists & inhibitors

Name
Glycogen Synthase Kinase 3, antagonists & inhibitors
Accession Number
DBCAT001442
Description
Not Available
Drugs
DrugDrug Description
AR-AO-14418Not Available
LY-2090314Ly2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.
TideglusibTideglusib was initially formulated for the treatment of Alzheimer and progressive supranuclear palsy. The raising interest for the use of tideglusib comes from the significant upregulation of GSK-3 in the...
6-bromoindirubin-3'-oximeNot Available
Drugs & Drug Targets
DrugTargetType
AR-AO-14418Glycogen synthase kinase-3 betatarget
TideglusibGlycogen synthase kinase-3 betatarget
6-bromoindirubin-3'-oximeGlycogen synthase kinase-3 betatarget